Современные представления о методах лечения мочекаменной болезни. Проблемы и перспективы

Аннотация

В литературном обзоре описаны основные методы лечения мочекаменной болезни. К таковым относят литотрипсию, фармакотерапию, лечение средствами природного происхождения (фитотерапия, минеральные воды). На основании многочисленных исследований последних лет можно предположить, что органическая матрица почечного камня является перспективной мишенью для литолиза.
Ключевые слова: мочекаменная болезнь, литотрипсия, фармакотерапия, фитотерапия, литолиз.

The literature review describes the main methods of treatment of kidney stone disease. They include lithotripsy, pharmacotherapy, treatment with natural products (phytotherapy, mineral water). Based on numerous studies of recent years, it can be assumed that the organic matrix of the kidney stone is a promising target for litholysis.
Key words: kidney stone disease, lithotripsy, pharmacotherapy, phytotherapy, litholysis.

Об авторах

Брюханов Валерий Михайлович

д.м.н., профессор, профессор кафедры фармакологии Алтайского государственного медицинского университета, г. Барнаул.
656038, г. Барнаул, пр-т Ленина, д. 40.
Тел.: (3852) 566812.
E-mail: bvm@agmu.ru

преподаватель кафедры общей и биологической химии, клинической лабораторной диагностики Алтайского государственного медицинского университета, г. Барнаул.
656038, г. Барнаул, пр-т Ленина, д. 40.
Тел.: (3852) 566938.
E-mail: ganna1704@mail.ru

Список литературы

1. Жариков А.Ю., Зверев Я.Ф., Брюханов В.М., Лампатов В.В. Механизм формирования кристаллов при оксалатном нефролитиазе. Нефрология. 2009; 13 (4): 37-50.
2. Зверев Я.Ф., Брюханов В.М., Лампатов В.В., Жариков А.Ю. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза. Нефрология. 2009; 13 (1): 39-50.
3. Conti C., Casati M., Colombo C et al. Synthesis of calcium oxalate trihydrate: New data by vibrational spectroscopy and synchrotron X-ray diffraction. Spectrochim Acta A Mol Biomol Spectrosc. 2015; 150: 721-730.
4. Rodgers A.L., Webber D.B. Hibberd. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist? Urolithiasis. 2015; 43 (6): 479-487.
5. Singh P., Enders F.T., Vaughan L.E. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community. Mayo Clin Proc. 2015; 90 (10): 1356-1365.
6. Spradling, K., Vernez S.L., Khoyliar C et al. Prevalence of Hyperoxaluria in Urinary Stone Formers: Chronological and Geographical Trends and a Literature Review. J Endourol. 2016; 30 (4): 469-465.
7. Sun X.Y., K Yu, Ouyang J.M. Time-dependent subcellular structure injuries induced by nano-/micron-sized calcium oxalatemonohydrate and dihydrate crystals. Mater Sci Eng C Mater Biol Appl. 2017; 79: 445-456.
8. Thongboonkerd V., Semangoen T., Chutipongtanate S. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature. Clin Chim Acta. 2006; 367 (1-2): 120-131.
9. Неймарк А.И., Поляков В.В., Титаренко Н.А. Влияние структуры уролитов на их прочностные свойства. Известия Алтайского государственного университета. 2000; 1: 95-97.
10. Поляков В.В., Неймарк А.И., Титаренко Н.А. Исследование прочностных свойств уролитов. Медицинская физика. 2001; (10): 79-83.
11. Поляков В.В., Неймарк А.И., Устинов Г.Г., Петрухно Е.В. Исследование элементного состава различных видов биоминеральных образований в организме человека. Известия Алтайского государственного университета. 2010; 1: 151-157.
12. Bazin Daudon D. M., Chevallier P et al. Synchrotron radiation techniques for structural characterisation of biological entities: an example with renal stone analysis. Ann Biol Clin (Paris). 2006; 64 (2): 125-139.
13. Schubert G. Stone analysis. Urol Res. 2006; 34 (2): 146-150.
14. Жариков А.Ю., Зверев Я.Ф., Брюханов В.М., Лампатов В.В. Механизм формирования кристаллов при оксалатном нефролитиазе. Нефрология. 2009; 13(4): 37-50.
15. Canales B.K., Anderson L., Higgins L. et al. Proteomic analysis of a matrix stone: a case report. Urol Res. 2009; 37(6): 323-329.
16. Canales B.K., Anderson L., Higgins L. et al. Proteome of human calcium kidney stones. Urology. 2010; 76(4): 1017.
17. Kaneko K., Nishii S., Izumi Y. et al. Proteomic Analysis after Sequential Extraction of Matrix Proteins in Urinary Stones Composed of Calcium Oxalate Monohydrate and Calcium Oxalate Dihydrate. Anal Sci. 2015; 31(9): 935-942.
18. Chaiyarit S. Calcium oxalate monohydrate crystals internalized into renal tubular cells are degraded and dissolved by endolysosomes / S. Chaiyarit, N. Singhto, V. Thongboonkerd. Chem Biol Interact. 2016; 246: 30-35.
19. Aggarwal K.P., Tandon S., Naik P.K. et al. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis. PLoS One. 2013; 8 (7):doi: 10.1371/journal.pone.0069916.
20. Aboutaleb H. Fluoroscopy free flexible ureteroscopy with holmium: Ytrium- aluminium-garnet laser lithotripsy for removal of renal calculi. Arab J Urol. 2016; 14 (2): 123-130.
21. Kroczak T., Scotland K.B., Chew B., Pace K.T. Shockwave lithotripsy: techniques for improving outcomes. World J Urol. 2017; 35 (9): 1341-1346.
22. Neisius A., Lipkin M.E., Rassweiler J.J. et al. Shock wave lithotripsy: the new phoenix? World J Urol. 2015; 33 (2): 213-221.
23. Scales Jr C.D., Lai J.C., Dick A.W. et al. Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. JAMA Surg. 2014; 149 (7): 648-653.
24. Wiesenthal J.D., Ghiculete D., D’A Honey R.J., Pace K.T. A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent? Endourol. 2011; 25 (3): 481-485.
25. Yuruk E., Binbay M., Ozgor F. et al. Comparison of shockwave lithotripsy and flexible ureteroscopy for the treatment of kidney stones in patients with a solitary kidney. J Endourol. 2015; 29 (4): 463-467.
26. Жебентяев А.А. Консервативное лечение и дистанционная литотрипсия при лечении мочекаменной болезни. Вестник Витебского государственного медицинского университета. 2007; 6(3): 5-12.
27. Дутов В.В. Дистанционная ударно-волновая литотрипсия: назад в будущее. РМЖ. 2014; 22 (29): 2077-2086.
28. Rassweiler Jens J., Geert G. Tailly, Christian Chaussy. Progress in Lithotriptor Technology. European Urology March. 2005; 3 (1): 17-36.
29. Мартов А.Г., Гудков А.В., Диамант В.М. и др. Сравнительное исследование эффективности электроимпульсного и электрогидравлического литотрипторов in vitro. Экспериментальная и клиническая урология. 2013; 4: 90-97.
30. Korean J., Gul Z., Monga M. Medical and dietary therapy for kidney stone prevention. Urol. 2014; 55 (12): 775-779.
31. Qaseem A., Dallas P., Forciea M.A. et al. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014; 161 (9): 659-667.
32. Sfoungaristos S., Gofrit O.N., Yutkin V. et al. Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options. Expert Opin Pharmacother. 2015; (8): 1209-1218.
33. Shah S., Calle J.C. Dietary and medical management of recurrent nephrolithiasis. Cleve Clin J Med. 2016; 83 (6): 463- 471.
34. Singh P., Knoedler J.J., Krambeck A.E. et al. Thiazide diuretic prophylaxis for kidney stones and the risk of diabetes mellitus. J Urol. 2014; 192 (6): 1700-1704.
35. Xu H., Zisman A.L., Coe F.L., Worcester E.M. Kidney stones:an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013; 14 (4): 435-447.
36. Campschroer T., Zhu Y., Duijvesz D. et al. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev. 2014; 4: doi: 10.1002/14651858.
37. Burrows P.K., Hollander J.E., Wolfson A.B. et al. Design and challenges of a randomized clinical trial of medical expulsive therapy (tamsulosin) for urolithiasis in the emergency department. Contemp Clin Trials. 2017; 52: 91-94.
38. McClinton S., Starr K., Thomas R. et al. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebocontrolled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials. 2014; doi: 10.1186/1745- 6215-15-238
39. Skolarikos A., Ghani K.R, Seit C. et al. Medical Expulsive Therapy in Urolithiasis: A Review of the Quality of the Current Evidence. Eur Urol Focus. 2017; 3 (1): 27-45.
40. Chutipongtanate S., Chaiyarit S., Thongboonkerd V. Citrate, not phosphate, can dissolve calcium oxalate monohydrate crystals and detach these crystals from renal tubular cells. Eur J Pharmacol. 2012; 689 (1): 219-225.
41. Krieger N.S., Asplin J.R., K.K. Frick et al. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. J Am Soc Nephrol. 2015; 26 (12): 3001-3008.
42. Manissorn J., Fong-Ngern K., Peerapen P., Thongboonkerd V. Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep. 2017; 7 (1): 1798.
43. Жариков А.Ю. Новые фармакологические подходы к лечению мочека- менной болезни. [диссертация] 14.03.06 Научно-исследовательский институт фармакологии томского научного центра сибирского отделения РАМН, Барнаул. 2012.
44. Yasui T., Okada A., Hamamoto S. et al. Pathophysiology-based treatment of urolithiasis. Int J Urol. 2017; 24 (1): 32-38.
45. Неймарк А.И., Каблова И.В., Ноздрачев Н.А. Применение фитопрепаратов в качестве средств профилактики послеоперационных осложнений у больных мочекаменной болезнью. Саратовский научно-медицинский журнал.
2011; 7 (2): 200-202.
46. Горленко В.Н., Горленко О.В., Лежнин С.И. и др. Пролит в комплексном лечении мочекаменной болезни. Урология. 2007; 1: 43-45.
47. Григорян З.Г., Локшин К.Л. Применение препарата Канефрон Н в урологической практике. Русский медицинский журнал. 2013; 21 (18): 924-929.
48. Mennuni G., Serio A., Fontana M. et al. Prevention and treatment of nephrolithiasis: a review on the role of spa therapy. Clin Ter. 2015; 166 (5): 344-356.
49. Zhong Y.S., Yu C.H., Ying H.Z. et al. Prophylactic effects of Orthosiphon stamineus Benth. extracts on experimental induction of calcium oxalate nephrolithiasis in rats. J Ethnopharmacol. 2012; 144 (3): 761-767.
50. Akanae W., Tsujihata M., Yoshioka I. et al. Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model. Urol Res. 2010; 38 (2): 89-96.
51. Wootisin S., Hossain R.Z., Yachantha C. et al. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats. J Urol. 2011; 185 (1): 323-328.
52. Aggarwal A., Singla S.K., Gandhi M. et al. Preventive and curative effects of Achyranthes aspera Linn. extract in experimentally induced nephrolithiasis. Indian J Exp Biol. 2012; 50 (3): 201-208.
53. Ahmed A., Wadud A., Jahan N. et al. Efcacy of Adiantum capillus veneris Linn in chemically induced urolithiasis in rats. J Ethnopharma- col. 2013; 146 (1): 411-416.
54. Alenzi M., Rahiman S., Tantry B.A. Antiurolithic effect of olive oil in a mouse model of ethylene glycol-induced urolithiasis. Investig Clin Urol. 2017; 58 (3): 210-216.
55. Amin B., Feriz H.M., Hariri A.T. et al. Protective effects of the aqueous extract of Crocus sativus against ethylene glycol induced nephrolithiasis in rats. XCLI J. 2015; 14: 411-422.
56. Atmani F, Slimani Y., Mimouni M. et al. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats. J Ethnopharmacol. 2004; 95 (1): 87-93.
57. Atmani F., Slimani Y., Mimouni M., Hacht B. Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int. 2003; 92 (1): 137-140.
58. Azaryan E., Malekaneh M., Shemshadi Nejad M., Haghighi F. Therapeutic Effects of Aqueous Extracts of Cerasus Avium Stem on Ethylene GlycolInduced Kidney Calculi in Rats. Urol J. 2017; 14 (4): 4024-4029.
59. Bafrani H.H., Parsa Y., Yadollah-Damavandi S. et al. Biochemical and Pathological Study of Hydroalcoholic Extract of Achillea millefolium L. on Ethylene Glycol-Induced Nephrolithiasis in Laboratory Rats. N Am J Med Sci. 2014; 6 (12): 638-642.
60. Barros M.E., Schor N., Boim M.A. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res. 2003; 30 (6): 374-379.
61. Bashir S., Gilani A.H., Siddiqui A.A. et al. Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytother Res. 2011; 24 (8): 1250-1255.
62. Bashir S., Gilani A.H. Antiurolithic effect of Bergenia ligulata rhizome: an explanation of the underlying mechanisms. J Ethnopharmacol. 2009; 122 (1): 106-116.
63. Bouanani S., Henchiri C., Migianu-Griffoni E. et al. Pharmacological and toxicological effects of Paronychia argentea in experimental calcium oxalate nephrolithiasis in rats. J Ethnopharmacol. 2010; 129 (1): 38-45.
64. Cao Z.G., Liu J.H., Radman A.M. et al. An experimental study of effect of different extracts of Alisma ori- entalis on urinary calcium oxalate stones formation in rats. Zhongguo Zhong Yao Za Zhi. 2003; 28 (11): 1072-1075.
65. Chaudhary A., Singla S.K., Tandon C. In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization. Indian J Pharm Sci. 2010; 72 (3): 340-345.
66. Cho H.J., Bae W.J., Kim S.J. et al. The inhibitory effect of an ethanol extract of the spores of Lygodium japonicum on ethylene glycol-induced kidney calculi in rats. Urolithiasis. 2014; 42 (4): 309-315.
67. de Cógáin M.R., Linnes M.P., Lee H.J. et al.Aqueous extract of Costus arabicus inhibits calcium oxalate crystal growth and adhesion to renal epithelial cellsю Urolithiasis. 2015; 43 (2): 119-124.
68. Das P., Kumar K., Nambiraj A. et al. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats. Int J Biol Macromol. 2017; 103: 621-629.
69. Gandhi M., Aggarwal M., Puri S., Singla S.K.. Prophylactic effect of coconut water (Cocos nucifera L.) on ethylene glycol induced nephrocalcinosis in male wistar rat. Int Braz J Urol. 2013; 39 (1): 108-117.
70. Golshan A., Hayatdavoudi P., Hadjzadeh M.A. et al. Kidney stone formation and antioxidant effects of Cynodon dactylon decoction in male Wistar rats. Avicenna J Phytomed. 2017; 7 (2): 180-190.
71. Hadjzadeh M.A., Khoei A., Hadjzadeh Z., Parizady M. Ethanolic extract of nigella sativa L seeds on ethylene glycol-induced kidney calculi in rats. Urol J. 2007; (2): 86-90.
72. Hadjzadeh M.A., Rad A.K., Rajaei Z. et al. The preventive effect of N-butanol fraction of Nigella sativa on ethylene glycol-induced kidney calculi in rats. Pharmacogn Mag. 2011; 7 (28): 338- 343.
73. Ilhan M., Ergene B., Süntar I. et al. Preclinical Evaluation of Antiurolithiatic Activity of Viburnum opulus L. on Sodium Oxalate-Induced Urolithiasis Rat Model. Evid Based Complement Alternat Med. 2014; (2014): doi: 10.1155/2014/578103.
74. Ingale K.G., Thakurdesai P.A., Vyawahare N.S. Effect of Hygrophila spinosa in ethylene glycol induced nephrolithiasis in rats. Indian J Pharmacol. 2012; 44 (5): 639-642.
75. Kanlaya R., Singhto N., Thongboonkerd. EGCG decreases binding of calcium oxalate monohydrate crystals onto renal tubular cells via decreased surface expression of alpha-enolase. J Biol Inorg Chem. 2016; 21 (3): 339-346.
76. Kaur N., Kaur B., Sirhindi G. Phytochemistry and Pharmacology of Phyllanthus niruri L. Phytother Res. 2017; 31 (7): 980-1004.
77. Khalili M., Jalali M.R., Mirzaei-Azandaryani M. Effect of hydroalcoholic extract of Hypericum perforatum L. leaves on ethylene glycol-induced kidney calculi in rats. Urol J. 2012; 9 (2): 472- 479.
78. Khan A., Bashir S., Khan S.R., Gilani A.H. Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complement Altern Med. 2011; (11): doi: 10.1186/1472- 6882- 11-96
79. Khajavi Rad. A., Hadjzadeh M.A., Rajaei Z. et al The beneficial effect of cynodon dactylon fractions on ethylene glycol-induced kidney calculi in rats. Urol J. 2011; 8 (3): 179-184.
80. Khan A., Khan S.R., Gilani A.H. Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res. 2012; 40 (6): 671-681.
81. Kumar B.N., Wadud A., Jahan N. et al. Antilithiatic effect of Peucedanum grande C. B. Clarke in chemically induced urolithiasis in rats. J Ethnopharmacol. 2016; (194): 1122-1129.
82. Li X., Liang Q., Sun Y. et al. Potential Mechanisms Responsible for the Antinephrolithic Effects of an Aqueous Extract of Fructus Aurantii. Evid Based Complement Alternat Med. 2015; (2015): doi: 10.1155/2015/491409.
83. Li X., Wang W., Su Y. et al. Inhibitory effect of an aqueous extract of Radix Paeoniae Alba on calcium oxalate nephrolithiasis in a rat model. Ren Fail. 2017; 39 (1): 120-129.
84. Liang Q., Li X., Zhou W. et al. An Explanation of the Underlying Mechanisms for the In Vitro and In Vivo Antiurolithic Activity of Glechoma longituba. Oxid Med Cell Longev. 2016; (2016): doi: 10.1155/2016/3134919.
85. Lin W.C., Lai M.T., Chen H.Y. et al. Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats. Urol Res. 2012; 40 (6): 655-661.
86. Mandavia D.R., Patel M.K., Patel J.C. et al. Anti-urolithiatic effect of ethanolic extract of Pedalium murex linn. fruits on ethylene glycolinduced renal calculi. Urol J. 2013; 10 (3): 946- 952.
87. Manjula K., Rajendran K., Eevera T., Kumaran S. Effect of Costus igneus stem extract on calcium oxalate urolithiasis in albino rats. Urol Res. 2012; 40 (5): 499-510.
88. Mehrabi S., Askarpour E., Mehrabi F., Jannesar R. Effects of hydrophilic extract of Nasturtium officinale on prevention of ethylene glycol induced renal stone in male Wistar rats. J Nephropathol. 2016; 5 (4): 123-127.
89. Mi J., Duan J., Zhang J. et al. Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats. 2012; 40 (2): 151-161.
90. Mittal A., Tandon S., Singla S.K., Tandon C. Cytoprotective and anti-apoptotic role of Terminalia arjuna on oxalate injured renal epithelial cells. Cytotechnology. 2017; 69 (2): 349-358.
91. Mittal A., Tandon S., Singla S.K., Tandon C. In vitro inhibition of calcium oxalate crystallization and crystal adherence to renal tubular epithelial cells by Terminalia arjuna. Urolithiasis. 2016; 44 (2): 117-125.
92. Nishihata M., Kohjimoto Y., Hara I. Effect of Kampo extracts on urinary stone formation: an experimental investigation. Int J Urol. 2013; 20 (10): 1032-1036.
93. Novaes Ada. S., da Silva Mota J., Barison A.et al. Diuretic and antilithiasic activities of ethanolic extract from Piper amalago (Piperaceae). Phytomedicine. 2014; 21 (4): 523-528.
94. Oliveira de R.B., Coelho E.B., Rodrigues M.R. et al. Effect of the Copaifera langsdorffii Desf. Leaf Extract on the Ethylene Glycol-Induced Nephrolithiasis in Rats. Evid Based Complement Alternat Med. 2013; (2013): doi: 10.1155/2013/131372.
95. Panigrahi P.N., Dey S., Sahoo M., Dan A. Antiurolithiatic and antioxidant efficacy of Musa paradisiaca pseudostem on ethylene glycolinduced nephrolithiasis in rat. Indian J Pharmacol. 2017; 49 (1): 77-83.
96. Rathod N.R., Biswas D., Chitme H.R. et al. Anti-urolithiatic effects of Punica granatum in male rats. J Ethnopharmacol. 2012; 140 (2): 234-238.
97. Saeidi J., Bozorgi H., Zendehdel A., Mehrzad J. Therapeutic effects of aqueous extracts of Petroselinum sativum on ethylene glycol-induced kidney calculi in rats. Urol J. 2012; 9 (1): 361-366.
98. Saha S., Verma R.J. Inhibition of calcium oxalate crystallisation in vitro by an ex- tract of Bergenia ciliate. Arab J Urol. 2013; 11 (2): 187-192.
99. Saha S., Shrivastav P.S., Verma R.J. Antioxidative mechanism involved in the preventive efficacy of Bergenia ciliata rhizomes against experimental nephrolithiasis in rats. Pharm Biol. 2014; 52 (6): 712-722.
100. Saha S., Verma R.J. Antinephrolithiatic and antioxidative efficacy of Dolichos biflorus seeds in a lithiasic rat model. Pharm Biol. 2014; 53 (1): 16-30.
101. Saremi J., Kargar-Jahroomi H., Poorahmadi M. Effect of Malva Neglecta Wallr on Ethylene Glycol Induced Kidney Stones. Urol J. 2015; 12 (6): 2387-2390.
102. Sharma I., Khan W., Parveen R. et al. Antiurolithiasis Activity of Bioactivity Guided Fraction of Bergenia ligulata against Ethylene Glycol Induced Renal Calculi in Rat. Biomed Res Int. 2017; (2017): 1-11.
103. Sikarwar I., Dey Y.N., Wanjari M.M. et al. Chenopodium album Linn. leaves prevent ethyleneglycol-induced urolithiasis in rats. J Ethnopharmacol. 2017; (195): 275-282.
104. Takawale R.V., Mali V.R., Kapase C.U., Bodhankar S.L. Effect of Lagenaria siceraria fruit powder on sodium oxalate induced urolithiasis in Wistar rats. J Ayurveda Integr Med. 2012; 3 (2): 75-79.
105. Tayef-Nasrabadi H., Sadigh-Eteghad S., Aghdam Z. The effects of the hydroalcohol extract of Rosa canina L. fruit on experimentally nephrolithiasic Wistar rats. Phytother Res. 2012; 26 (1): 78-85.
106. Xiang M., Zhang S., Lu J. et al. Antilithic effects of extracts from Urtica dentata hand on calcium oxalate urinary stones in rats. J Huazhong Univ Sci Technolog Med Sci. 2011; 31 (5): 673- 677.
107. Zhou J., Jin J., Li X. et al. Total flavonoids of Desmodium styracifolium atenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats. Urolithiasis. 2017: doi: 10.1007/ s00240-017- 0985-y
108. Минушкин О.Н., Сергеев А.В. Применение препарата пролит у больных желчнокаменной болезнью в сочетании с мочекаменной болезнью. Эффективная фармакотерапия. 2008; (10): 14-17.
109. Crescenti A., Puiggròs F., Colomé A. et al. Antiurolithiasic effect of a plant mixture of Herniaria glabra, Agropyron repens, Equisetum arvense and Sambucus nigra (Herbensurina®) in the prevention of experimentally induced nephrolithiasis in rats. Arch Esp Urol. 2015; 68 (10): 739-749.
110. Frackowiak A., Skibiński P., Gaweł W. et al. Synthesis of glycoside derivatives of hydroxyanthraquinone with ability to dissolve and inhibit formation of crystals of calcium oxalate. Potential compounds in kidney stone therapy. Eur J Med Chem. 2010; 45 (3): 1001-1007.
111. Ghaeni F.A., Amin B., Hariri A.T. et al. Antilithiatic effects of crocin on ethylene glycol-induced lithia- sis in rats. Urolithiasis. 2014; 42 (6): 549-558.
112. Patel P., Patel M., Saralai M., Gandhi T. Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats. J Young Pharm. 2012; 4 (3): 164- 170.
113. Patel P.K., Patel M.A., Vyas B.A. et al. Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl. (Solanaceae) against ethylene glycol induced urolithiasis in rats. J Ethnopharmacol. 2012; 144 (1): 160-170.
114. Bashir S., Gilani A.H. Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol. 2011; 651 (1): 168-175.
115. Ilbey Y.O., Ozbek E., Simsek A. et al. Effects of pomegranate juice on hyperoxaluria-induced oxidative stress in the rat kidneys. Ren Fail. 2009; 31 (6): 522-531.
116. Melo K.R., Camara R.B., Queiroz M.F. et al. Evaluation of sulfated polysaccharides from the brown seaweed Dictyopteris justii as antioxidant agents and as inhibitors of the formation of calcium oxalate crystals. Molecules. 2013; 18 (12): 14543- 14563.
117. Vanachayangkul P., Chow N., Khan S.R., Buterweck V. Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats. Urological Research. 2011; 39 (3): 189-195.
118. Xiang S., Zhou J., Li J. et al. Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats. Urolithiasis. 2015; 43 (5): 433- 439.
119. Mital A., Tandon S., Singla S.K., Tandon C. Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis. PLoS One. 2016; 11 (9): 1-33.
120. Неймарк А.И., Вольф В.А., Сибуль И.Э. и др. Использование минеральной воды «Серебряный ключ» в комплексном лечении больных с уролитиазом. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2002; (1): 47-48.
121. Неймарк А.И., Давыдов А.В. Адресная реабилитация больных нефролитиазом на курортах Алтайского края. Саратовский научно-медицинский журнал. 2011; 7 (2): 57-61.
122. Неймарк А.И., Давыдов А.В., Бунков В.В. и др. Применение питьевой минеральной воды в комплексном лечении больных нефролитиазом. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2005; (3): 32.
123. Неймарк А.И., Давыдов А.В. Использование минеральной воды «Серебряный ключ» в послеоперационном лечении больных нефролитиазом, перенесших дистанционную ударно-волновую литотрипсию. Урология. 2003; (4): 47-46.
124. Неймарк А.И., Давыдов А.В., Каблова И.В. и др. Клинико-экспериментальные возможности минеральной воды «Серебряный ключ» в лечении мочекаменной болезни. Вестник алтайской науки. 2013; (2): 152-156.
125. Неймарк А.И., Давыдов А.В., Каблова И.В., Сибуль И.Э. Использование минеральной воды у больных нефролитиазом, перенесших дистанционную ударно-волновую литотрипсию. Казанский медицинский журнал. 2008; 89 (3):
261-264.
126. Неймарк А.И., Давыдов А.В., Каблова И.В. Лечебно-профилактическая и реабилитационная терапия больных нефролитиазом с использованием минеральной воды «Белокурихинская восточная 2» на стационарном и санаторно-курортном этапах лечения. Паллиативная медицина и реабилитация. 2007 (4): 12-15.
127. Sujatha D., Singh K., Vohra M. et al. Antilithiatic Activity of phlorotannin rich extract of Sarghassum Wightii on Calcium Oxalate Urolithiais — InVitro and In Vivo Evaluation. Int Braz J Urol. 2015; 41 (3): 511-520.
128. Schulman A., Chaimowit M., Choudhury M. et al. Antioxidant and Renoprotective Effects of Mushroom Extract: Implication in Prevention of Nephrolithiasis. J Clin Med Res. 2016; 8 (12): 908-915.